MEDI9447 (oleclumab)

oleclumab · MedImmune LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI9447 (oleclumab), covering 2023-10-03 to 2023-10-03. Get the full timeline:

Most recent: Clinical Trial Update: MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. [Phase 1, Phase 2]